CORRIGENDUM to Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy

CORRIGENDUM to Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy

Bibliographic Details
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-04-01
Series:	Neuroscience Insights
Online Access:	https://doi.org/10.1177/2633105520921294

Similar Items

Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
by: Darija Šoltić, et al.
Published: (2020-03-01)

Spinal muscular atrophy in Venezuela: quantitative analysis of SMN1 and SMN2 genes
by: Yuri Yépez, et al.
Published: (2020-06-01)

The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
by: Niko Hensel, et al.
Published: (2020-02-01)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Bowerman, M, et al.
Published: (2017)

SMN post-translational modifications in spinal muscular atrophy
by: Giulietta M. Riboldi, et al.
Published: (2023-02-01)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Melissa Bowerman, et al.
Published: (2017-08-01)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Bowerman, M, et al.
Published: (2017)

Molecular and Epidemiological Characterization of SMN Genes in Cuban Patients with Spinal Muscular Atrophy
by: Fabián Lombillo-Alfonso, et al.
Published: (2020-01-01)

Molecular And Epidemiological Characterization Of SMN Genes In Cuban Patients With Spinal Muscular Atrophy
by: Fabián Lombillo, et al.
Published: (2019-05-01)

SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
by: Valeria Valsecchi, et al.
Published: (2023-11-01)

The spinal muscular atrophy disease protein SMN is linked to the Golgi network.
by: Chen-Hung Ting, et al.
Published: (2012-01-01)

Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
by: Amparo Garcia-Lopez, et al.
Published: (2018-05-01)

NSC Physiological Features in Spinal Muscular Atrophy: SMN Deficiency Effects on Neurogenesis
by: Raffaella Adami, et al.
Published: (2022-12-01)

Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy
by: Tejal Aslesh, et al.
Published: (2022-01-01)

Targeting SR proteins improves SMN expression in spinal muscular atrophy cells.
by: Claribel D Wee, et al.
Published: (2014-01-01)

Deletion analysis of SMN and NAIP genes in Tunisian patients with spinal muscular atrophy
by: Imen Rekik, et al.
Published: (2013-01-01)

P423: SMN1 SMN2 gene-specific sequencing enhances the clinical sensitivity of spinal muscular atrophy diagnostic testing
by: Matthew Avenarius, et al.
Published: (2023-01-01)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
by: Niba, Emma Tabe Eko, et al.
Published: (2022)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
by: Niba, Emma Tabe Eko, et al.
Published: (2022)

P719: SMN1 deletion and silent carrier screening for spinal muscular atrophy
by: Poh San Lai, et al.
Published: (2024-01-01)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
by: Emma Tabe Eko Niba, et al.
Published: (2022-01-01)

Investigation of a recombinant SMN protein delivery system to treat spinal muscular atrophy
by: Anderton Ryan, et al.
Published: (2014-03-01)

Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene
by: Žarkov Marija, et al.
Published: (2015-01-01)

Evaluation of Mean Percentage of Full-Length SMN Transcripts as a Molecular Biomarker of Spinal Muscular Atrophy
by: Marianna Maretina, et al.
Published: (2022-10-01)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
by: Winkelsas, AM, et al.
Published: (2021)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
by: Winkelsas, AM
Published: (2020)

SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
by: Wishart, T, et al.
Published: (2010)

The Importance of Digging into the Genetics of <i>SMN</i> Genes in the Therapeutic Scenario of Spinal Muscular Atrophy
by: Mar Costa-Roger, et al.
Published: (2021-08-01)

Hepatocyte-intrinsic SMN deficiency drives metabolic dysfunction and liver steatosis in spinal muscular atrophy
by: Leow, Damien Meng-Kiat, et al.
Published: (2024)

Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls.
by: Christian Czech, et al.
Published: (2015-01-01)

Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
by: Audrey M. Winkelsas, et al.
Published: (2021-03-01)

The Smn-independent beneficial effects of trichostatin A on an intermediate mouse model of spinal muscular atrophy.
by: Hong Liu, et al.
Published: (2014-01-01)

Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor
by: Qing Xie, et al.
Published: (2024-02-01)

Genomic Variability in the Survival Motor Neuron Genes (<i>SMN1</i> and <i>SMN2</i>): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development
by: Matthew E. R. Butchbach
Published: (2021-07-01)

Mutational analysis of SMN gene in patients with spinal muscular atrophy and the correlation between mutation and the severity of clinical manifestations
by: Almagul Nagimtaeeva, et al.
Published: (2017-09-01)

Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy
by: Sang-Hyeon Hann, et al.
Published: (2024-02-01)

In Vivo Translatome Profiling in Spinal Muscular Atrophy Reveals a Role for SMN Protein in Ribosome Biology
by: Paola Bernabò, et al.
Published: (2017-10-01)

Systems biology investigation of cAMP modulation to increase SMN levels for the treatment of spinal muscular atrophy.
by: Sean G Mack, et al.
Published: (2014-01-01)

SMN1 and NAIP Genes Deletions in Different Types of Spinal Muscular Atrophy in Khuzestan Province, Iran
by: Gholamreza Mohamadian, et al.
Published: (2011-12-01)

Analysis of the survival of motor neuron (SMN1) gene mutations in Spinal Muscular Atrophy through models
by: Owen, N, et al.
Published: (2002)